Zafgen_June_2018_577_29577

Loading viewer...

investor_presentation

Format: PDF investor_presentation

This document presents Zafgen's investor update on ZGN-1061, highlighting positive Phase 2 data for a diabetes treatment at the American Diabetes Association conference.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Zafgen

View all →

investor_presentation

investor_presentation

Similar investor_presentations from other companies

Browse all →

investor_presentation

Faraday Future

investor_presentation

Crocs